Cerebras Systems (NASDAQ:CBRS) is approaching its first earnings report as a public company with execution rather than demand as the key variable to watch, according to Wedbush analysts.
Demand risk is "almost zero," according to Wedbush, given Cerebras's existing deals with OpenAI and Amazon, meaning results will largely reflect how well management delivers against its own targets.
Driving the optimism is TSMC capacity. The analysts believe the foundry will deliver at least modest upside to expected wafer output in 2026 and 2027, which could translate into incremental system sales for Cerebras.
That dynamic is further helped by tightening accelerator availability across the industry and growing memory sourcing constraints, a challenge that matters less for Cerebras because its chips rely on SRAM rather than high-bandwidth memory.
The firm also flags the company's next-generation WSE-4 chip as a potential positive catalyst. While Cerebras has not provided a formal timeline, Wedbush notes that general speculation points to a late 2026 or early 2027 launch and ramp, with the new design expected to improve both margins and revenue.
Wedbush also credits management with building in some conservatism at the IPO stage, suggesting that simply executing to plan could yield upside to current estimates.
Longer term, the firm argues Cerebras's story is less about near-term beats and more about capturing share in a rapidly expanding AI accelerator market. Analysts point to continued growth in inference demand, potential incremental customers supported by TSMC output, and worsening memory pricing constraints as tailwinds that should work in the company's favor.
The firm considers 2028 the appropriate reference year as the first in which OpenAI-related investment costs begin to moderate and the company reaches what it views as meaningful revenue and operational scale.
Wedbush maintains a Buy rating and $270 price target on Cerebras based on a 40x price-to-earnings multiple applied to its 2028 EPS estimate of $6.03, plus net cash of $28.19 per share.